A detailed history of Bank Of America Corp transactions in Chimerix Inc stock. As of the latest transaction made, Bank Of America Corp holds 13,095 shares of CMRX stock, worth $12,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,095
Previous 13,045 0.38%
Holding current value
$12,964
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $43 - $52
50 Added 0.38%
13,095 $11,000
Q1 2024

May 15, 2024

SELL
$0.91 - $1.26 $45 - $63
-50 Reduced 0.38%
13,045 $13,000
Q4 2023

Feb 14, 2024

SELL
$0.9 - $1.06 $330,577 - $389,346
-367,308 Reduced 96.56%
13,095 $12,000
Q2 2023

Aug 14, 2023

SELL
$1.1 - $1.54 $195,043 - $273,060
-177,312 Reduced 31.79%
380,403 $460,000
Q1 2023

May 12, 2023

SELL
$1.19 - $2.09 $9,828 - $17,261
-8,259 Reduced 1.46%
557,715 $702,000
Q4 2022

Feb 10, 2023

BUY
$1.67 - $2.35 $380,768 - $535,811
228,005 Added 67.46%
565,974 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$1.81 - $2.76 $550,373 - $839,244
304,074 Added 897.11%
337,969 $652,000
Q2 2022

Aug 12, 2022

SELL
$1.34 - $5.34 $160,247 - $638,599
-119,588 Reduced 77.92%
33,895 $70,000
Q1 2022

May 16, 2022

BUY
$4.58 - $6.8 $289,025 - $429,120
63,106 Added 69.83%
153,483 $703,000
Q4 2021

Feb 08, 2022

BUY
$5.23 - $7.18 $345,509 - $474,332
66,063 Added 271.71%
90,377 $581,000
Q3 2021

Nov 15, 2021

SELL
$5.94 - $8.75 $68,909 - $101,508
-11,601 Reduced 32.3%
24,314 $150,000
Q2 2021

Sep 13, 2021

BUY
$7.54 - $9.79 $270,799 - $351,607
35,915 New
35,915 $288,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $86.7M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.